More and more imaging researchers are starting to examine the potential of using fibroblast activation protein inhibitors (FAPI) to manage patients with suspected cardiovascular disease.
The BENEFIT-HF trial, scheduled to begin enrollment in the months ahead, could significantly increase the number of patients eligible for CVRx's Barostim therapy.
Shockwave Medical, now a part of Johnson & Johnson MedTech, sits at the top of the IVL market, but things are starting to get more competitive. Boston Scientific gained its own IVL system when it acquired Bolt Medical in 2025.
Gene-editing drugs have shown potential to treat a wide variety of diseases, and this will be one of the first in cardiovascular medicine to begin human trials.
Emergency departments that employ nonphysician practitioners probably improve patient access to timely care. However, these EDs also order 5.3% more imaging than their physician-only counterparts.
The American Roentgen Ray Society (ARRS), Strategic Radiology and Bracco Diagnostics have separately elevated early- and mid-career radiologists to heightened educational opportunities.
Lyme disease patients treated for “brain fog” may develop compensatory alterations in white matter that show up on MRI and correspond—unexpectedly—with slow but sound cognitive performance.
Pregnant women who felt stressed by healthcare disruptions caused by the COVID-19 pandemic radiated the unease to their developing offspring. The effects were observable on fetal MRI of both brainstem structure and functional activity.
"We expected to see a significant improvement in outcomes for patients with severe or rapidly progressing cardiogenic shock who underwent early ECMO treatment," one specialist said.
Two late-breaking clinical trials presented at the VIVA Foundation’s VIVA22 conference in Las Vegas highlighted the impact drug-coated balloons can make on patient outcomes.
Though it is not yet clear why some COVID patients develop thyroiditis and some do not, researchers maintain that their findings “support the hypothesis of a direct thyroid gland involvement in SARS‐CoV‐2 infection.”
